Investor presentation and Q&A

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces that, further to its successful SweetBiotix sampling on 24 June 2026, Stephen O'Hara, CEO of OptiBiotix will provide a live presentation to investors via its Investor Hub platform on Thursday 2 July 2026 at 2pm (BST).

The event will provide investors an overview of the commercial progress of its first-generation products, routes to market for its second generation products, and discuss the feedback from its successful investor sampling of its first SweetBiotix product.

Interested investor should register to attend via this link: https://optibiotix.com/webinars/PQ55VP-optibiotix-investor-webinar

View the full announcement and submit questions to management via our website: https://optibiotix.com/link/r6g3wP

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), OptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease. Since the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like SlimBiome®, WellBiome®, SweetBiotix® and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.